Table 3. Predictive value of biomarkers for progression-free survival (univariate analysis with continuous values).
HR | 95%-CI | p | |
---|---|---|---|
Value at D1 | |||
VEGF-C (ng/ml) J0 | 0.93 | (0.70-1.26) | 0.66 |
sE-SELECTIN (ng/ml) J0 | 0.99 | (0.94-1.04) | 0.62 |
THROMBOSPONDIN (μg/ml) J0 | 0.99 | (0.96-1.04) | 0.96 |
VEGF (ng/ml) J0 | 1.96 | (0.98-3.92) | 0.06 |
PIGF (pg/ml) J0 | 0.98 | (0.91-1.06) | 0.68 |
SCF sR/c-kit (ng/ml) J0 | 0.99 | (0.66-1.49) | 0.98 |
Value at D7 | |||
VEGF-C (ng/ml) J7 | 0.91 | (0.63-1.31) | 0.61 |
sE-SELECTIN (ng/ml) J7 | 1.01 | (0.96-1.06) | 0.70 |
THROMBOSPONDIN (μg/ml) J7 | 0.98 | (0.93-1.03) | 0.39 |
VEGF (ng/ml) J7 | 2.15 | (0.92-5.06) | 0.08 |
PIGF (pg/ml) J7 | 1.01 | (0.96-1.05) | 0.84 |
SCF sR/c-kit (ng/ml) J7 | 1.04 | (0.74-1.45) | 0.83 |
Difference (D7-D1) | |||
VEGF-C (ng/ml) J7 - J0 | 0.89 | (0.45-1.77) | 0.73 |
sE-SELECTIN (ng/ml) J7 - J0 | 1.07 | (0.99-1.16) | 0.08 |
THROMBOSPONDIN (μg/ml) J7 - J0 | 0.98 | (0.93-1.03) | 0.36 |
VEGF (ng/ml) J7 - J0 | 0.40 | (0.04-3.91) | 0.43 |
PIGF (pg/ml) J7 - J0 | 1.01 | (0.97-1.06) | 0.66 |
SCF sR/c-kit (ng/ml) J7 - J0 | 1.45 | (0.53-3.95) | 0.47 |